What is AmnioPatch™?
AmnioPatch™ is a surgical allograft derived from human amniotic membrane that is a protective covering and physical barrier from external irritants. Amniotic membrane also contains collagen, fibronectin, and hyaluronic acid, along with a combination of growth factors, cytokines, and anti-inflammatory proteins such as interleukin-1 receptor antagonist.1
About Amniotic Membrane Allografts
When prepared for use as an allograft, the amniotic membrane is harvested immediately after birth, cleaned, and sterilized.
Many products available using the amnion membrane are being studied for the treatment of a variety of conditions, including chronic full-thickness diabetic lower-extremity ulcers, venous ulcers, knee osteoarthritis, plantar fasciitis, burns and ophthalmic conditions. There are also properties within amnion membrane that have been associated with the reduction of scarring or adhesions.2
Applications of AmnioPatch™
The use of amniotic tissue for assistance with wound healing has been advocated for over 65 years. Amniotic membrane tissue is indicated for the management of ocular wounds, as well as to control minor bleeding.
The allograft maintains a moist environment, which helps provide a physiologically favorable milieu for ocular wound management. Amniotic membrane transplantation has also become a popular alternative in situations where frequent topical lubrication often fails.3 Some of these scenarios include tarsorrhaphy, punctal occlusion, tissue adhesives, and conjunctival flaps to repair persistent epithelial defects.
Furthermore, human amniotic membrane is used as a treatment for ocular surface reconstruction, and is currently being studied for the treatment of various conditions, including skin wounds, burns, leg ulcers, and prevention of tissue adhesion in surgical procedures.4
Amniotic membrane products have also been used for:
Chemical burns of the ocular surface
Corneal epithelial defects
High-risk corneal transplant, trabeculectomy
In conjunction with superficial keratectomy
Symblepharon and fornix reconstruction
1. Gupta, A., Kedige, S. D., & Jain, K. (2015). Amnion and Chorion Membranes: Potential Stem Cell Reservoir with Wide Applications in Periodontics. International Journal of Biomaterials, 2015, 274082. http://doi.org/10.1155/2015/274082
2. Subach, B. R., & Copay, A. G. (2015). The Use of a Dehydrated Amnion/Chorion Membrane Allograft in Patients Who Subsequently Undergo Reexploration after Posterior Lumbar Instrumentation. Advances in Orthopedics, 2015, 501202. http://doi.org/10.1155/2015/501202
3. Meller, D., Pauklin, M., Thomasen, H., Westekemper, H., & Steuhl, K.-P. (2011). Amniotic Membrane Transplantation in the Human Eye. Deutsches Ärzteblatt International, 108(14), 243–248. http://doi.org/10.3238/arztebl.2011.0243
4. Malhotra, C., & Jain, A. K. (2014). Human amniotic membrane transplantation: Different modalities of its use in ophthalmology. World Journal of Transplantation, 4(2), 111–121. http://doi.org/10.5500/wjt.v4.i2.111
About the Distributor: Lone Peak Biologics
Lone Peak Biologics is a distributor of high-quality human cell and tissue-based products based in Utah. Products go through comprehensive clinical and laboratory testing to ensure they are safe and effective for patient use. We comply with US FDA regulations for Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/P) identified in 21 CFR Part 1271 and Section 361 of the Public Health Service Act. Compliance with these regulations ensures the delivery of quality allograft products to healthcare providers with confidence. Furthermore, our proprietary cryopreservation process maximizes the viability and the concentration of our products, allowing our human tissue products to deliver maximum quality in a variety of form factors, some of which include industry-leading biologics products like StemShot® and AmnioPatch™.